Cargando…

301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic

Detalles Bibliográficos
Autores principales: Valente, A.C., Lopes Almeida, C., Costa, M.J., Nogueira Costa, I.C., Reis, J.S., Freitas, M.C.B., Teixeira, C.M., Gonçalves, M.V., Fernandes, A.C., Costa, A.S.A., Caeiro, C.L.B., Osório, L., Augusto, I.M., Barbosa, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472540/
http://dx.doi.org/10.1016/j.annonc.2022.07.435
_version_ 1784789323856478208
author Valente, A.C.
Lopes Almeida, C.
Costa, M.J.
Nogueira Costa, I.C.
Reis, J.S.
Freitas, M.C.B.
Teixeira, C.M.
Gonçalves, M.V.
Fernandes, A.C.
Costa, A.S.A.
Caeiro, C.L.B.
Osório, L.
Augusto, I.M.
Barbosa, M.
author_facet Valente, A.C.
Lopes Almeida, C.
Costa, M.J.
Nogueira Costa, I.C.
Reis, J.S.
Freitas, M.C.B.
Teixeira, C.M.
Gonçalves, M.V.
Fernandes, A.C.
Costa, A.S.A.
Caeiro, C.L.B.
Osório, L.
Augusto, I.M.
Barbosa, M.
author_sort Valente, A.C.
collection PubMed
description
format Online
Article
Text
id pubmed-9472540
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-94725402022-09-14 301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic Valente, A.C. Lopes Almeida, C. Costa, M.J. Nogueira Costa, I.C. Reis, J.S. Freitas, M.C.B. Teixeira, C.M. Gonçalves, M.V. Fernandes, A.C. Costa, A.S.A. Caeiro, C.L.B. Osório, L. Augusto, I.M. Barbosa, M. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-09 2022-09-13 /pmc/articles/PMC9472540/ http://dx.doi.org/10.1016/j.annonc.2022.07.435 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Valente, A.C.
Lopes Almeida, C.
Costa, M.J.
Nogueira Costa, I.C.
Reis, J.S.
Freitas, M.C.B.
Teixeira, C.M.
Gonçalves, M.V.
Fernandes, A.C.
Costa, A.S.A.
Caeiro, C.L.B.
Osório, L.
Augusto, I.M.
Barbosa, M.
301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic
title 301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic
title_full 301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic
title_fullStr 301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic
title_full_unstemmed 301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic
title_short 301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic
title_sort 301p hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472540/
http://dx.doi.org/10.1016/j.annonc.2022.07.435
work_keys_str_mv AT valenteac 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic
AT lopesalmeidac 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic
AT costamj 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic
AT nogueiracostaic 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic
AT reisjs 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic
AT freitasmcb 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic
AT teixeiracm 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic
AT goncalvesmv 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic
AT fernandesac 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic
AT costaasa 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic
AT caeiroclb 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic
AT osoriol 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic
AT augustoim 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic
AT barbosam 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic